國家衛生研究院 NHRI:Item 3990099045/5348
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 907766      在线人数 : 913
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/5348


    题名: Tumor-associated macrophage: Its role in tumor angiogenesis
    作者: Lee, CC;Liu, KJ;Huang, TS
    贡献者: National Institute of Cancer Research
    摘要: Macrophages are important cells in wound healing, providing aids for tissue cell growth, tissue matrix remodeling and angiogenesis. Solid tumor comprises not only tumor cells, but also tissue matrix and many stromal cells such as fibroblasts and macrophages. Accumulating research results have suggested tumor-associated macrophages (TAMs) functioning in tumor cell proliferation, tumor cell migration and invasion, and tumor angiogenesis. In this review article, we review data from clinical investigations and animal studies to demonstrate the association of TAMs with tumor angiogenesis. We also discuss results of several mechanistic studies to provide possible mechanisms for TAMs-associated angiogenesis. By interacting with cancer cells, TAMs can be induced to express more cytokines and tissue matrix-degrading enzymes, such as matrix metalloproteinases, plasminogen activators and cathepsin B, that are either direct angiogenic factors or tissue matrix modulators responsible for promoting tumor angiogenesis. The angiogenic effect of TAMs can be neutralized by antagonizing antibodies or competitive soluble receptors of interleukin-6, interleukin-8 and tumor necrosis factor-alpha, suggesting the involvement of these cytokines in TAMs-associated angiogenesis. With evidence indicating TAM's tumor-promoting roles, many investigations have been undertaken to study the potential of using TAMs as the therapeutic target. Photosensitizer can be labeled to the scavenger receptor class A to target TAMs in cancer photodynamic therapy. In addition, macrophages can be engineered to serve as vehicles to carry drug or genes to the hypoxic areas of tumor. More detailed mechanisms regarding the interaction between TAMs and tumor still need to be explored, and a thorough understanding of this interaction will provide some helpful conceptual suggestions for the future cancer therapy.
    日期: 2006-08
    關聯: Journal of Cancer Molecules. 2006 Aug;2(4):135-140.
    Link to: http://mupnet.com/JOCM%202%284%29%20135.htm
    显示于类别:[劉柯俊] 期刊論文
    [黃智興] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    NCA2011011005.pdf1215KbAdobe PDF1782检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈